BIOMAT Database Logo BIOMAT Database Logo

[Candida carrier state in diffuse toxic goiter and hypothyroidism]. 1987

L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Functional state of the stomach in patients with diffuse toxic goiter and hypothyroidism].
June 1975, Vrachebnoe delo,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Monoamine oxidase activity in diffuse toxic goiter and primary hypothyroidism].
January 1969, Problemy endokrinologii,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Lipid peroxidation in patients with diffuse toxic goiter and hypothyroidism].
January 1998, Likars'ka sprava,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Posttreatment hypothyroidism in diffuse toxic goiter. A complication or evolution?].
November 1990, Anales de medicina interna (Madrid, Spain : 1984),
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Water-salt balance in patients with diffuse toxic goiter and hypothyroidism].
January 1997, Likars'ka sprava,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Ways to decrease postoperative hypothyroidism in patients with diffuse toxic goiter].
January 1994, Vestnik khirurgii imeni I. I. Grekova,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Prevention of postoperative hypothyroidism in surgical treatment of diffuse toxic goiter].
January 2001, Khirurgiia,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Development of diffuse toxic goiter in the presence of prior hypothyroidism].
June 2007, Problemy endokrinologii,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Diffuse toxic goiter].
September 1984, Fel'dsher i akusherka,
L A Ivanova, and Z O Karaev, and P A Sil'nitskiĭ, and A B Mogilevskiĭ, and A S Egor'kova
[Diffuse toxic goiter].
January 1984, Meditsinskaia sestra,
Copied contents to your clipboard!